Europe Opioids Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Product (Immediate Release Short Acting Opioid and Extended Release Long Acting Opioid), Application (Pain Management, Anesthesia, Diarrhea Suppression, Cough Suppression, De-Addiction, and Others), Route of Administration (Oral, Injectable, and Transdermal Patch), and Distribution Channel (Hospital Pharmacies and Retail Pharmacies)

No. of Pages: 90    |    Report Code: BMIRE00030996    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Opioids Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Opioids Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Opioids Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Geriatric population
5.2 Market Opportunities
  • 5.2.1 Strategic Initiatives by Market Players
5.3 Future Trends
  • 5.3.1 Increasing Government Initiatives Focusing on the Development of Medication to Prevent and Treat Opioid Use Overdose and Disorder
5.4 Impact of Drivers and Restraints

6. Europe Opioids Market Regional Analysis

6.1 Europe Opioids Market Overview
6.2 Europe Opioids Market Revenue 2020-2030 (US$ Million)
6.3 Europe Opioids Market Forecast Analysis

7. Europe Opioids Market Analysis – by Product

7.1 Immediate Release Short Acting Opioid
  • 7.1.1 Overview
  • 7.1.2 Immediate Release Short Acting Opioid: Europe Opioids Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Extended Release Long Acting Opioid
  • 7.2.1 Overview
  • 7.2.2 Extended Release Long Acting Opioid: Europe Opioids Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Opioids Market Analysis – by Application

8.1 Pain Management
  • 8.1.1 Overview
  • 8.1.2 Pain Management: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Anesthesia
  • 8.2.1 Overview
  • 8.2.2 Anesthesia: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Diarrhea Suppression
  • 8.3.1 Overview
  • 8.3.2 Diarrhea Suppression: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cough Suppression
  • 8.4.1 Overview
  • 8.4.2 Cough Suppression: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.5 De-Addiction
  • 8.5.1 Overview
  • 8.5.2 De-Addiction: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe Opioids Market Analysis – by Route of Administration

9.1 Oral
  • 9.1.1 Overview
  • 9.1.2 De-Addiction: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Injectable
  • 9.2.1 Overview
  • 9.2.2 De-Addiction: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Transdermal Patch
  • 9.3.1 Overview
  • 9.3.2 De-Addiction: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)

10. Europe Opioids Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Opioids Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 Europe Opioids Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 UK: Europe Opioids Market Breakdown, by Product
    • 10.1.1.1.2 UK: Europe Opioids Market Breakdown, by Application
    • 10.1.1.1.3 UK: Europe Opioids Market Breakdown, by Route of Administration
  • 10.1.1.2 Germany: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Opioids Market Breakdown, by Product
    • 10.1.1.2.2 Germany: Europe Opioids Market Breakdown, by Application
    • 10.1.1.2.3 Germany: Europe Opioids Market Breakdown, by Route of Administration
  • 10.1.1.3 France: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 France: Europe Opioids Market Breakdown, by Product
    • 10.1.1.3.2 France: Europe Opioids Market Breakdown, by Application
    • 10.1.1.3.3 France: Europe Opioids Market Breakdown, by Route of Administration
  • 10.1.1.4 Russia: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Opioids Market Breakdown, by Product
    • 10.1.1.4.2 Russia: Europe Opioids Market Breakdown, by Application
    • 10.1.1.4.3 Russia: Europe Opioids Market Breakdown, by Route of Administration
  • 10.1.1.5 Italy: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Opioids Market Breakdown, by Product
    • 10.1.1.5.2 Italy: Europe Opioids Market Breakdown, by Application
    • 10.1.1.5.3 Italy: Europe Opioids Market Breakdown, by Route of Administration
  • 10.1.1.6 Rest of Europe: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Opioids Market Breakdown, by Product
    • 10.1.1.6.2 Rest of Europe: Europe Opioids Market Breakdown, by Application
    • 10.1.1.6.3 Rest of Europe: Europe Opioids Market Breakdown, by Route of Administration

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Opioids Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Endo International plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Mallinckrodt Plc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Neuraxpharm Pharmaceuticals SL
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Hikma Pharmaceuticals Plc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Rusan Pharma Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Teva Pharmaceutical Industries Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

  1. Endo International plc
  2. Mallinckrodt Plc
  3. Neuraxpharm Pharmaceuticals SL
  4. Hikma Pharmaceuticals Plc
  5. Rusan Pharma Ltd
  6. Teva Pharmaceutical Industries Ltd
europe-opioids-market